Toll Free: 1-888-928-9744
Toll Free: 1-888-928-9744
Published: Dec, 2016 | Pages:
71 | Publisher: Global Markets Direct
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)
Array BioPharma Inc - Product Pipeline Review - 2016 Summary Global Markets Direct's, 'Array BioPharma Inc - Product Pipeline Review - 2016', provides an overview of the Array BioPharma Inc's pharmaceutical research and development focus. The report provides comprehensive information on the therapeutics under development by Array BioPharma Inc, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis. The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data. Scope - The report provides a snapshot of the pipeline therapeutic landscape of Array BioPharma Inc - The report provides overview of Array BioPharma Inc including its business description, key facts, and locations and subsidiaries - The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities - The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages - The report assesses Array BioPharma Inc's pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type - The report features Array BioPharma Inc's out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects Reasons To Buy - Evaluate Array BioPharma Inc's strategic position with total access to detailed information on its product pipeline - Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Identify and understand important and diverse types of therapeutics under development for Array BioPharma Inc - Identify potential new clients or partners in the target demographic - Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics - Devise corrective measures for pipeline projects by understanding Array BioPharma Inc's pipeline depth and focus of pipeline therapeutics - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
Table of Contents
Table of Contents 2 List of Tables 5 List of Figures 5 Introduction 6 Global Markets Direct Report Coverage 6 Array BioPharma Inc Snapshot 7 Array BioPharma Inc Overview 7 Key Facts 7 Array BioPharma Inc - Research and Development Overview 8 Key Therapeutic Areas 8 Array BioPharma Inc - Pipeline Review 11 Pipeline Products by Stage of Development 11 Pipeline Products - Monotherapy 12 Pipeline Products - Combination Treatment Modalities 13 Pipeline Products - Partnered Products 14 Partnered Products/Combination Treatment Modalities 15 Pipeline Products - Out-Licensed Products 16 Out-Licensed Products/Combination Treatment Modalities 17 Array BioPharma Inc - Pipeline Products Glance 19 Array BioPharma Inc - Late Stage Pipeline Products 19 Pre-Registration Products/Combination Treatment Modalities 19 Phase III Products/Combination Treatment Modalities 20 Array BioPharma Inc - Clinical Stage Pipeline Products 21 Phase II Products/Combination Treatment Modalities 21 Phase I Products/Combination Treatment Modalities 22 Array BioPharma Inc - Early Stage Pipeline Products 23 Preclinical Products/Combination Treatment Modalities 23 Discovery Products/Combination Treatment Modalities 24 Array BioPharma Inc - Drug Profiles 25 AR-00457679 - Drug Profile 25 Product Description 25 Mechanism Of Action 25 R&D Progress 25 AR-460770 - Drug Profile 26 Product Description 26 Mechanism Of Action 26 R&D Progress 26 AR-523 - Drug Profile 27 Product Description 27 Mechanism Of Action 27 R&D Progress 27 AR-786 - Drug Profile 28 Product Description 28 Mechanism Of Action 28 R&D Progress 28 ARRY-111 - Drug Profile 29 Product Description 29 Mechanism Of Action 29 R&D Progress 29 ARRY-382 - Drug Profile 30 Product Description 30 Mechanism Of Action 30 R&D Progress 30 ARRY-797 - Drug Profile 32 Product Description 32 Mechanism Of Action 32 R&D Progress 32 ARRY-954 - Drug Profile 35 Product Description 35 Mechanism Of Action 35 R&D Progress 35 binimetinib - Drug Profile 36 Product Description 36 Mechanism Of Action 36 R&D Progress 36 binimetinib + encorafenib - Drug Profile 45 Product Description 45 Mechanism Of Action 45 R&D Progress 45 encorafenib - Drug Profile 49 Product Description 49 Mechanism Of Action 49 R&D Progress 49 Small Molecules for Inflammation - Drug Profile 53 Product Description 53 Mechanism Of Action 53 R&D Progress 53 Array BioPharma Inc - Pipeline Analysis 54 Array BioPharma Inc - Pipeline Products by Target 54 Array BioPharma Inc - Pipeline Products by Route of Administration 56 Array BioPharma Inc - Pipeline Products by Molecule Type 57 Array BioPharma Inc - Pipeline Products by Mechanism of Action 58 Array BioPharma Inc - Dormant Projects 60 Array BioPharma Inc - Discontinued Pipeline Products 61 Discontinued Pipeline Product Profiles 61 ARRY-797 61 AZD-8330 61 binimetinib 61 GDC-0425 62 GDC-0994 62 Mutant cKIT Inhibitor for GIST 62 rabusertib 62 selumetinib sulfate 62 Array BioPharma Inc - Company Statement 63 Array BioPharma Inc - Locations And Subsidiaries 69 Head Office 69 Other Locations & Subsidiaries 69 Appendix 70 Methodology 70 Coverage 70 Secondary Research 70 Primary Research 70 Expert Panel Validation 70 Contact Us 70 Disclaimer 71
List of Tables
Array BioPharma Inc, Key Facts 7 Array BioPharma Inc - Pipeline by Indication, 2016 9 Array BioPharma Inc - Pipeline by Stage of Development, 2016 11 Array BioPharma Inc - Monotherapy Products in Pipeline, 2016 12 Array BioPharma Inc - Combination Treatment Modalities in Pipeline, 2016 13 Array BioPharma Inc - Partnered Products in Pipeline, 2016 14 Array BioPharma Inc - Partnered Products/ Combination Treatment Modalities, 2016 15 Array BioPharma Inc - Out-Licensed Products in Pipeline, 2016 16 Array BioPharma Inc - Out-Licensed Products/ Combination Treatment Modalities, 2016 17 Array BioPharma Inc - Pre-Registration, 2016 19 Array BioPharma Inc - Phase III, 2016 20 Array BioPharma Inc - Phase II, 2016 21 Array BioPharma Inc - Phase I, 2016 22 Array BioPharma Inc - Preclinical, 2016 23 Array BioPharma Inc - Discovery, 2016 24 Array BioPharma Inc - Pipeline by Target, 2016 55 Array BioPharma Inc - Pipeline by Route of Administration, 2016 56 Array BioPharma Inc - Pipeline by Molecule Type, 2016 57 Array BioPharma Inc - Pipeline Products by Mechanism of Action, 2016 59 Array BioPharma Inc - Dormant Developmental Projects,2016 60 Array BioPharma Inc - Discontinued Pipeline Products, 2016 61 Array BioPharma Inc, Other Locations 69
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.
